4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001872398-26-000002
Chief Executive Officer gave up 4,050 shares (to pay taxes)
- Chief Executive Officer acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chung Jane Chief Executive Officer | 2026-03-01 | Option exercise | +688 | 14,579 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-01 | Option exercise | +2,500 | 17,079 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-01 | Shares withheld for taxes | −1,271 | $20.47 | $26,017 | 15,808 | D |
| Chung Jane Chief Executive Officer | 2026-03-02 | Option exercise | +7,750 | 23,558 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-02 | Shares withheld for taxes | −2,779 | $20.55 | $57,108 | 20,779 | D |
| Derivatives | |||||||
| Chung Jane Chief Executive Officer | 2026-03-01 | Option exercise · Restricted Stock Units (RSUs) | −688 | 688 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-01 | Option exercise · Restricted Stock Units (RSUs) | −2,500 | 5,000 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-02 | Option exercise · Restricted Stock Units (RSUs) | −7,750 | 23,250 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-02 | Grant or award · Restricted Stock Units (RSUs) | +40,000 | 40,000 | D | ||
| Chung Jane Chief Executive Officer | 2026-03-02 | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | D | ||
Loading xslF345X05/form4-03032026_110347.xml…